Improving awareness of women with hypertension: ROAR (Rural, Obese, At Risk) Career Enhancement Core
Improving awareness of women with hypertension: ROAR (Rural, Obese, At Risk) Career Enhancement Core
批准号:
10714535
负责人:
Daria Ilatovskaya
金额:
$45.11万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-01 至 2028-08-31
关键词:
AcademyAddressAdultAgeAmerican Heart AssociationAwardAwarenessBiologicalBlood PressureBlood Pressure MonitorsCardiovascular DiseasesCause of DeathCessation of lifeClinicalCollaborationsCommunicationCommunitiesCommunity OutreachDevelopmentEducationEducational MaterialsEducational workshopEmerging TechnologiesEnsureEquipmentEventFacultyFamilyFoundationsGoalsGrantHealthcareHeart DiseasesHistorically Black Colleges and UniversitiesHypertensionImprove AccessIndividualInstitutionLaboratoriesLeadLeadershipMedicalMedical StudentsMentorsMentorshipMethodsMissionMonitorNeeds AssessmentObesityPatientsPerceptionPharmaceutical PreparationsPhysiciansPopulations at RiskPostdoctoral FellowProgram SustainabilityRecommendationResearchResearch PersonnelResearch Project GrantsResourcesRiskRisk FactorsRuralSchoolsScientistSelf PerceptionSex DifferencesStudentsTrainingTraining and EducationUniversitiesWomanWomen&aposs Healthbiomedical scientistblood pressure controlcardiovascular disorder educationcardiovascular disorder riskcardiovascular healthcardiovascular risk factorcareercollegecommunity engagementcommunity partnershipdesignempowermentexperiencehealth care availabilityhealthspanhypertension controlimprovedinnovationinterestmembermenmodifiable risknext generationoutreachpre-doctoralprematuresabbaticalsexstudent trainingsuccesssummer programsynergismteachertoolundergraduate student
中文摘要
超过三分之一的女性患有心脏病,许多人没有意识到这些风险。高血压
是心血管疾病(CVD)的主要可改变的危险因素,在美国约47%的成年人患有
高血压。在~85%的病例中,高血压的原因不明,只有~50%的患者
服用药物可将血压控制在推荐的水平。一个严重的障碍
限制心血管疾病导致的过早死亡是缺乏对心血管疾病风险的认识。职业生涯
增强核心(CEC)旨在开发一个关于SABV的全面教育平台
心血管疾病:提高对女性心血管疾病和失控高血压风险的认识和教育
通过社区外展,跨越卫生领域。CEC对Roar的成功至关重要。这个
CEC的目标是为研究、医疗和医疗机构之间的长期关系奠定基础
以及GA、MS和SC的下层社区,并提高对女性和
SABV在高血压教育、指导、策略控制中的思考
伙伴关系和社区参与研究人员的培训。Roar-CEC有3个目标。
目标1是建立一个文化多元化的生物医学科学家研究渠道,这些科学家在
心脑血管疾病的SABV场。这一目标将为SABV的研究职业发展提供机会
研究,培养多样化的科学劳动力,并在不同的地方促进SABV的机械研究
职业生涯阶段。目标2是建立一个经过培训的科学家的社区外展渠道
提高对SABV的认识,促进男女最佳心血管保健。
ROAR-CEC将利用和加强现有的社区伙伴关系,以参与外联活动
在当地的学校、大学和学校向男性和女性宣传心血管风险
HBCU。目标3是使社区能够自我监督并找出改进的障碍
获得医疗保健服务。这将通过创新的教育材料和
障碍的定性评估。Roar-CEC采取全面的培训和
在心血管疾病的SABV中开展教育,提高社区对心血管疾病风险的认识。我们的
跨学科团队为解决高危人群的这些重要问题做好了独特的准备
美国南部。Roar-CEC的影响将是培养下一代从事
在与妇女健康和SABV有关的研究中,改变对以下问题的普遍看法和偏见
女性的健康和高血压的危险因素,并支持发展新的,自我意识,
由研究人员、教育工作者、医生和社区成员组成的可持续、有动力的社区。
Roar将创造协同效应,将改变学术、临床和社区对
心血管健康对女性的重要性。
英文摘要
More than 1 in 3 women are living with heart disease and many are unaware of the risks. Hypertension
is a major modifiable risk factor for cardiovascular disease (CVD), and ~47% of adults in the US have
hypertension. In ~85% of cases, the cause of hypertension is unknown and only ~50% of patients
taking medication achieve blood pressure (BP) control to recommended levels. A critical barrier to
limiting premature death from CVD is lack of awareness surrounding the risks of CVD. The Career
Enhancement Core (CEC) is designed to develop a comprehensive educational platform on SABV in
CVD to increase awareness and education of CVD and the risks of uncontrolled hypertension in women
across the health span through community outreach. The CEC is critical to the success of ROAR. The
goals of the CEC are to develop a foundation for long-term relationships among the research, medical
and lay communities in GA, MS and SC, and bring greater awareness to the risk of CVD in women and
the consideration of SABV in the control of hypertension through education, mentorship, strategic
partnerships, and training of community-engaged researchers. The ROAR-CEC has 3 objectives.
Objective 1 is to develop a culturally diverse research pipeline of biomedical scientists trained in the
field of SABV in CVD. This Objective will provide research career enhancement opportunities in SABV
research, train a diverse scientific workforce, and promote mechanistic studies in SABV at different
career stages. Objective 2 is to establish a community outreach pipeline of scientists trained to
increase awareness of SABV and promote optimal cardiovascular healthcare for men and women.
ROAR-CEC will leverage and strengthen existing community partnerships to engage in outreach to
promote awareness about cardiovascular risk to men and women at local schools, colleges and
HBCUs. Objective 3 is to empower the community to self-monitor and identify barriers to improving
access to healthcare. This will be accomplished through innovative educational materials and
qualitative assessment of barriers. ROAR-CEC takes a comprehensive approach to training and
education in SABV in CVD and increasing community awareness of the risks of CVD. Our
interdisciplinary team is uniquely prepared to address these important issues in at-risk populations in
the Southern US. The impact of ROAR-CEC will be to train the next generation of scientists engaged
in research related to women’s health and SABV, to change common perceptions and biases regarding
women’s health and hypertension risk factors, and support the development of a new, self-aware,
sustainable, and motivated community of researchers, educators, physicians and community members.
ROAR will create synergy that will transform academic, clinical and community awareness of the
importance of cardiovascular health in women.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitochondria-mediated effects and therapeutic potential of Atrial Natriuretic Peptide in salt-sensitive hypertension
-
批准号:10676800
-
项目类别:
-
资助金额:$52.54万
-
财政年份:2020
-
负责人:Daria Ilatovskaya
-
依托单位:
Mitochondria-mediated effects and therapeutic potential of Atrial Natriuretic Peptide in salt-sensitive hypertension
-
批准号:10442162
-
项目类别:
-
资助金额:$56.94万
-
财政年份:2020
-
负责人:Daria Ilatovskaya
-
依托单位:
Mitochondria-mediated effects and therapeutic potential of Atrial Natriuretic Peptide in salt-sensitive hypertension
-
批准号:10472035
-
项目类别:
-
资助金额:$52.54万
-
财政年份:2020
-
负责人:Daria Ilatovskaya
-
依托单位:
Mitochondria-Mediated Effects and Therapeutic Potential of Atrial Natriuretic Peptide in Salt-Sensitive Hypertension Diversity Supplement
-
批准号:10337412
-
项目类别:
-
资助金额:$2.7万
-
财政年份:2020
-
负责人:Daria Ilatovskaya
-
依托单位:
The involvement of ATP-dependent inhibition of ENaC in ARPKD cystogenesis
-
批准号:10419229
-
项目类别:
-
资助金额:$2.11万
-
财政年份:2018
-
负责人:Daria Ilatovskaya
-
依托单位:
The involvement of ATP-dependent inhibition of ENaC in ARPKD cystogenesis
-
批准号:9146873
-
项目类别:
-
资助金额:$8.82万
-
财政年份:2015
-
负责人:Daria Ilatovskaya
-
依托单位:
海外基金